Featured Research

from universities, journals, and other organizations

Shift Work Linked To Organ Disease, Study Suggests

Date:
April 11, 2008
Source:
University of Toronto
Summary:
Disruption of an individual's natural sleep-wake cycle has been determined to be a contributing factor in the development of organ disease. The human body works according to a natural 24 hour sleep-wake cycle, also referred to as a circadian rhythm, which controls body temperature, sleep/wake timing, and the way our organs and body systems work together.

Disruption of an individual’s natural sleep-wake cycle has been determined to be a contributing factor in the development of organ disease. The findings of U of T researchers were recently published in the Journal of American Physiology.

The human body works according to a natural 24 hour sleep-wake cycle, also referred to as a circadian rhythm, which controls body temperature, sleep/wake timing, and the way our organs and body systems work together. Past research has shown that irregular sleep patterns and shift work take a toll on even the healthiest person over an extended period.

“As researchers, we accept that biological clocks and their rhythms are important for health, but there are virtually no experimental data demonstrating a casual link between circadian dysregulation and organ pathology,” says researcher Martin Ralph, a Professor out of the Department of Psychology at U of T, and one of the lead researchers on the project.

“We knew that circadian rhythm disruption had been linked with reduced longevity so we decided to try and find out where, why and how longevity is compromised.”

The team, headed by Dr. Michael Sole, and which included researchers from the Peter Munk Cardiac Centre at the University Health Network and the departments of Psychology and Physiology at the University of Toronto, found that coordination of the many circadian clocks throughout the body is critical for normal healthy organs and that long-term disruption of normal circadian rhythms can ultimately result in heart and kidney disease.


Story Source:

The above story is based on materials provided by University of Toronto. Note: Materials may be edited for content and length.


Cite This Page:

University of Toronto. "Shift Work Linked To Organ Disease, Study Suggests." ScienceDaily. ScienceDaily, 11 April 2008. <www.sciencedaily.com/releases/2008/04/080409205727.htm>.
University of Toronto. (2008, April 11). Shift Work Linked To Organ Disease, Study Suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/04/080409205727.htm
University of Toronto. "Shift Work Linked To Organ Disease, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2008/04/080409205727.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins